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Submitted Aug 7, 2012; accepted Sep 25, 2012.INVITED COMMENTARYThomas S. Huber, MD, PhD, Gainesville, FlaThe authors have developed a risk assessment tool to predict
perioperative morbidity and mortality after infrainguinal bypass
in patients with critical limb ischemia using the National Surgical
Quality Improvement Program database. They reported an overall
mortality rate of 2.9% with a major morbidity rate of 19%. Not
surprisingly, they identiﬁed advanced age, prior revasculariza-
tion/amputation, tissue loss, dialysis dependence, severe cardiac
disease, emergent operation, and functional dependence as predic-
tors of adverse outcome. The sum of the weighted values assigned
to these predictors correlated well with the adverse outcomes in
their internal validation and the model itself compared favorably
with others reported in the literature. Despite the quality of the
study and the importance of predicting perioperative outcome, it
is not clear how the model should be used in clinical practice. Crit-
ical limb ischemia is a difﬁcult problem with poor long-term
outcomes in terms of wound healing, ambulation, limb salvage,
functional independence, and survival. The model deﬁnes perio-
perative outcome in a select group of patients presumably deemed
adequate risk to undergo open revascularization. Unfortunately, itfails to model any of these other important outcome measures that
may be far more relevant from a patient perspective. It is not clear
that the data can be used to support an endovascular approach as
an alternative to open revascularization as suggested by the
authors. With the widespread proliferation of the endovascular
therapies, most providers (ie, vascular surgeons, interventional
radiologists, cardiologists) have adopted an “endovascular ﬁrst”
approach and presumably many of the patients in the current study
would not have been endovascular candidates based upon their
distribution of occlusive disease and/or extent of tissue loss.
Notably, 70% of the patients in the current study had tissue loss,
and 55% had undergone a previous revascularization or amputa-
tion. Furthermore, it is conceivable that “medical management”
with local wound care or major amputation may be a better treat-
ment option in the highest-risk cohort of patients with critical limb
ischemia. I commend the authors for their excellent contribution
and look forward to their planned, future studies detailing perio-
perative and longer-term outcomes after the other treatment
options in this difﬁcult patient population.
